Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Review H2 2014

Topics: Leukemia, Chronic myelogenous leukemia, Acute myeloid leukemia Pages: 2 (848 words) Published: October 30, 2014
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2014: Order report by calling Rnrmarketsresearch.com at +1 888 391 5441 OR send an email on sales@rnrmarketresearch.com with your contact details.

Chronic myelogenous (or myeloid or myelocytic) leukemia (CML), also known as chronic granulocytic leukemia (CGL), is a cancer of the white blood cells. It is a form of leukemia characterized by the increased and unregulated growth of predominantly myeloid cells in the bone marrow and the accumulation of these cells in the blood. CML is a clonal bone marrow stem cell disorder in which a proliferation of mature granulocytes (neutrophils, eosinophils and basophils) and their precursors is found. It is a type of myeloproliferative disease associated with a characteristic chromosomal translocation called the Philadelphia chromosome. CML is now largely treated with targeted drugs called tyrosine kinase inhibitors (TKIs) which have led to dramatically improved long term survival rates since the introduction of the first such agent in 2001. These drugs have revolutionized treatment of this disease and allow most patients to have a good quality of life when compared to the former chemotherapy drugs. In Western countries it accounts for 15-20% of all adult leukemias and 14% of leukemias overall (including the paediatric population).

This report provides comprehensive information on the therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) and special features on late-stage and discontinued projects. Global Markets Direct’s report features...
Continue Reading

Please join StudyMode to read the full document

You May Also Find These Documents Helpful

  • Chronic Myeloid Leukemia Essay
  • Chronic myelogenous leukemia Essay
  • Chronic Myeloid Leukemia Essay
  • Chronic Myelogenous Leukemia Research Paper
  • Chronic Myelogenous Leukemia (Cml) Essay
  • Anatomy: Acute Myeloid Leukemia Essay
  • Chronic Myelogenous Leukemia: Causes, Symptoms, and Treatment Essay
  • Acute Myeloid Leukemia Essay

Become a StudyMode Member

Sign Up - It's Free